Teleflex has recalled a percutaneous thrombolytic device kit due to reports that a component could detach from the device and embolize. The Food and Drug Administration has classified this as a Class 1 recall, the most serious type, due to the potential for serious adverse health consequences or death. The company said it has received seven complaints about the issue, but no reports of long-term patient complications. It advises health care providers to immediately stop using and return all affected product, and identify all patients currently exposed to it. Providers also may report adverse reactions or quality problems using the product to the FDA's MedWatch program
 

Related News Articles

Headline
The Agency for Healthcare Research and Quality seeks comments through July 1 to inform development of a potential Consumer Assessment of Healthcare…
Headline
Health care providers should not use non-invasive prenatal screening tests alone to diagnose genetic abnormalities due to the potential for false results…
Headline
Robyn Begley, chief nursing officer for the AHA and CEO of the American Organization for Nursing Leadership, today issued a statement in response to a decision…
Chairperson's File
One week in early March every year is designated as Patient Safety Awareness Week, a national recognition to encourage everyone to learn more about health care…
Headline
To support National Patient Safety Awareness Week, which starts Sunday, the American Society for Health Care Risk Management has developed free tip sheets and…
Headline
The Agency for Healthcare Research and Quality this week named as its new director Robert “Bob” Otto Valdez, Robert Wood Johnson Foundation professor…